Select Medical Holdings Corp. Files Q3 2024 10-Q
Ticker: SEM · Form: 10-Q · Filed: Oct 31, 2024 · CIK: 1320414
Sentiment: neutral
Topics: 10-Q, financials, healthcare
Related Tickers: SEM
TL;DR
SELECT MEDICAL HOLDINGS CORP (SEM) filed their 10-Q for Q3 2024. Financials look steady.
AI Summary
Select Medical Holdings Corp. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter and the first nine months of the year. Key financial metrics and business segment information are provided, reflecting the company's ongoing operations in the healthcare services sector.
Why It Matters
This filing provides investors and analysts with the latest financial performance data for Select Medical Holdings Corp., crucial for understanding the company's current health and future prospects in the healthcare services industry.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags or significant negative disclosures.
Key Players & Entities
- SELECT MEDICAL HOLDINGS CORP (company) — Filer of the 10-Q
- 20240930 (date) — End of the reporting period
- 20241031 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is for the period ending September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on October 31, 2024.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0001320414.
What is the Standard Industrial Classification (SIC) code for Select Medical Holdings Corp.?
The SIC code for Select Medical Holdings Corp. is 8060, which falls under SERVICES-HOSPITALS.
What is the fiscal year end for Select Medical Holdings Corp.?
The fiscal year end for Select Medical Holdings Corp. is December 31.
Filing Stats: 4,570 words · 18 min read · ~15 pages · Grade level 20 · Accepted 2024-10-31 16:31:26
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share SEM New York Stock Exchange
Filing Documents
- sem-20240930.htm (10-Q) — 2102KB
- sem-930202410qxex311.htm (EX-31.1) — 12KB
- sem-930202410qxex312.htm (EX-31.2) — 12KB
- sem-930202410qxex321.htm (EX-32.1) — 7KB
- 0001628280-24-044570.txt ( ) — 9402KB
- sem-20240930.xsd (EX-101.SCH) — 47KB
- sem-20240930_cal.xml (EX-101.CAL) — 93KB
- sem-20240930_def.xml (EX-101.DEF) — 215KB
- sem-20240930_lab.xml (EX-101.LAB) — 600KB
- sem-20240930_pre.xml (EX-101.PRE) — 438KB
- sem-20240930_htm.xml (XML) — 1771KB
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 24 ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 47 ITEM 4.
CONTROLS AND PROCEDURES
CONTROLS AND PROCEDURES 47 PART II OTHER INFORMATION 48 ITEM 1.
LEGAL PROCEEDINGS
LEGAL PROCEEDINGS 48 ITEM 1A.
RISK FACTORS
RISK FACTORS 48 ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 48 ITEM 3. DEFAULTS UPON SENIOR SECURITIES 48 ITEM 4. MINE SAFETY DISCLOSURES 48 ITEM 5. OTHER INFORMATION 48 ITEM 6. EXHIBITS 49
SIGNATURES
SIGNATURES 2 Table of Contents
: FINANCIAL INFORMATION
PART I: FINANCIAL INFORMATION
CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Select Medical Holdings Corporation Condensed Consolidated Balance Sheets (unaudited) (in thousands, except share and per share amounts) December 31, 2023 September 30, 2024 ASSETS Current Assets: Cash and cash equivalents $ 84,006 $ 191,468 Accounts receivable 940,335 1,060,007 Prepaid income taxes 22,726 8,669 Current portion of interest rate cap contract 58,962 — Other current assets 151,617 144,053 Total Current Assets 1,257,646 1,404,197 Operating lease right-of-use assets 1,188,616 1,321,045 Property and equipment, net 1,023,561 1,040,383 Goodwill 3,513,170 3,555,022 Identifiable intangible assets, net 329,916 312,565 Other assets 376,722 369,449 Total Assets $ 7,689,631 $ 8,002,661 LIABILITIES AND EQUITY Current Liabilities: Overdrafts $ 30,274 $ 14,173 Current operating lease liabilities 245,400 249,832 Current portion of long-term debt and notes payable 70,329 42,785 Accounts payable 174,312 170,711 Accrued and other liabilities 728,150 768,203 Total Current Liabilities 1,248,465 1,245,704 Non-current operating lease liabilities 1,025,867 1,163,406 Long-term debt, net of current portion 3,587,675 3,098,957 Non-current deferred tax liability 143,306 95,557 Other non-current liabilities 110,303 98,593 Total Liabilities 6,115,616 5,702,217 Commitments and contingencies (Note 14) Redeemable non-controlling interests 26,297 30,455 Stockholders' Equity: Common stock, $ 0.001 par value, 700,000,000 shares authorized, 128,369,492 and 129,539,724 shares issued and outstanding at 2023 and 2024, respectively 128 130 Capital in excess of par 493,413 858,741 Retained earnings 751,856 1,056,320 Accumulated other comprehensive income 42,907 — Total Stockholders' Equity 1,288,304 1,915,191 Non-controlling interests 259,414 354,798 Total Equity 1,547,718 2,269,989 Total Liabilities and Equity $ 7,689,631 $ 8,002,661 The accompanying notes are an integral part of these conden